• CENTRE FOR COMMERCIALIZATION OF CANCER IMMUNOTHERAPY C3I



C3i is attending the NeoAntigen Summit!

C3i will attend the Neoantigen Summit in Boston from November 14th to 16th to hear about the latest developments in neoantigen discovery and monitoring. This meeting will bring together pioneers from the field and industry leaders to discuss clinical translation and the development of neoantigen-based therapies. Get in touch to know more about C3i and the services we offer in our Biomarker and Diagnostic unit to support personalized therapies.

 

Contact: Danielle de Verteuil

ddeverteuil@centrec3i.com